首页|利伐沙班联合导管溶栓在老年颅内出血患者急性上肢深静脉血栓形成的血小板/淋巴细胞比率及预后影响

利伐沙班联合导管溶栓在老年颅内出血患者急性上肢深静脉血栓形成的血小板/淋巴细胞比率及预后影响

扫码查看
目的 分析利伐沙班联合导管溶栓在老年颅内出血患者急性上肢深静脉血栓形成的血小板/淋巴细胞比率及预后影响。方法 选取南京医科大学第一附属医院2018 年10 月~2022 年9 月收治的老年颅内出血并发急性上肢深静脉血栓患者 43 例导管拔除后予以利伐沙班口服的患者作为观察组,并选取同期43 例单纯溶栓患者为对照组。评估观察两组患者治疗后的临床疗效、血小板/淋巴细胞比率(PLR)等情况。结果 观察组总有效率 93。02%(40/43)显著高于对照组 79。07%(31/43),差异有统计学意义(χ2=4。038,P<0。05)。观察组血浆二聚体(D-D)、纤维蛋白原(Fib)、PLR均显著低于对照组[(0。71±0。14)mg/L vs。(0。83±0。22)mg/L、(3。52±0。38)g/L vs。(4。37±0。42)g/L、(220。83±53。1)vs。(281。12±89。73)],凝血酶原时间(PT)、活化部分凝血酶时间(APTT)均显著高于对照组[(15。14±1。31)s vs。(14。18±1。52)s、(44。29±4。53)s vs。(40。28±4。17)s],差异均有统计学意义(t=3。018、9。841、3。784、3。137、4。271,P<0。05)。治疗2 周后,观察组患肢与健肢肘上、肘下 20 cm处周径差值显著低于对照组[(1。52±0。23)cm vs。(1。83±0。27)cm、(1。02±0。12)cm vs。(1。69±0。35)cm],差异均有统计学意义(t=5。731、11。874,P<0。05)。观察组不良反应发生率低于对照组,但差异无统计学意义(P>0。05)。结论 利伐沙班联合导管溶栓治疗急性上肢深静脉血栓,可以取得一定的临床疗效,DVT形成的生理机制与PLR相关,PLR指标对DVT的形成及预后评估有帮助。
Platelet/lymphocyte ratio and prognostic impact of livoxaban combined with catheter thrombolysis in elderly patients with acute upper extremity deep vein thrombosis complicating intracranial hemorrhage
Objective To analyze platelet/lymphocyte ratio(PLR)and prognostic impact of sandbath combined with catheter thrombolysis in elderly patients with acute upper extremity deep vein thrombosis(DVT)complicating intracranial hemorrhage.Methods Aged patients with intracranial hemorrhage combined with acute upper extremity DVTs admitted to our hospital from October 2018 to September 2022 were selected.Based on the inclusion and exclusion criteria,43 patients who took rivoroxaban orally after catheter removal were selected as the observation group,and 43 patients who received thrombolysis alone during the same period were selected as the control group.Clinical efficacy and PLR were evaluated and compared after treatment.Results The overall efficacy of 93.02%(40/43)was significantly higher in the observation group than in the control group(31/43)(χ2 =4.038,P<0.05).The levels of plasma D-D(D-dimer),FIB(Fibrinogen)and PLR in the observation group were significantly lower than those in the control group[(0.71±0.14)mg/L vs.(0.83±0.22)mg/l,(3.52±0.38)g/L vs.(4.37±0.42)g/l,(220.83±53.1)vs.(281.12±89.73)],prothrombin time(PT)and activated partial thromboplastin time(APTT)were significantly higher than those in the control group[(15.14±1.31)s vs.(14.18±1.52)s,(44.29±4.53)s vs.(40.28±4.17)s],the difference was significant(t=3.018,9.841,3.784,3.137,4.271,P<0.05).After 2 weeks of treatment,the limb circumference diameter and above the elbow in the observation group were significantly lower than in the control group[(1.52±0.23)cm vs.(1.83±0.27)cm,(1.02±0.12)cm vs.(1.69±0.35)cm](t=5.731,11.874,P<0.05).The incidence of adverse reactions was lower than in the control group,with no statistical significance(P>0.05).Conclusion Livoxaban combined with catheter thrombolysis is effective in the treatment of acute upper extremity DVT.The physiological mechanism of DVT formation is related to PLR,and PLR index is helpful for the evaluation of DVT's formation and prognosis.

Intracranial hemorrhage old ageAcute upper extremity deep vein thrombosisPlatelet/lymphocyte ratio

唐玥、田雅丽、颜伟、吴娟

展开 >

210029 南京医科大学第一附属医院(江苏省人民医院)急诊ICU

210029 南京医科大学第一附属医院(江苏省人民医院)危重症科

210029 南京医科大学第一附属医院(江苏省人民医院)神经外科

老年颅内出血患者 急性上肢深静脉血栓 血小板/淋巴细胞比率

江苏省"六大人才高峰"高层次人才项目(第十五批)

WSW-006

2024

中华保健医学杂志
中国人民解放军总后勤部卫生部保健局

中华保健医学杂志

CSTPCD
影响因子:0.477
ISSN:1674-3245
年,卷(期):2024.26(1)
  • 21